Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
暂无分享,去创建一个
M G Rinaldi | J. Wingard | J. Karp | W. Merz | M. Rinaldi | W G Merz | T. R. Johnson | R. Saral | J R Wingard | T R Johnson | J E Karp | R Saral | M. G. Rinaldi | T. Johnson
[1] J. Perfect,et al. Fluconazole and Candida krusei fungemia. , 1991, The New England journal of medicine.
[2] J. Karp,et al. Response to empiric amphotericin B during antileukemic therapy-induced granulocytopenia. , 1991, Reviews of infectious diseases.
[3] M. A. McIlroy. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis. , 1991, The Journal of infectious diseases.
[4] J. Galgiani. Fluconazole, a new antifungal agent. , 1990, Annals of internal medicine.
[5] L. Young,et al. From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. , 1990, The Journal of infectious diseases.
[6] B. Leventhal,et al. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Sobel,et al. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. , 1989, Reviews of infectious diseases.
[8] J. Wingard,et al. Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole. , 1987, The American journal of medicine.
[9] W. Scheld,et al. Role of fibronectin in the pathogenesis of candidal infections. , 1987, Reviews of infectious diseases.
[10] J. Karp,et al. Increased incidence of fungemia caused by Candida krusei , 1986, Journal of clinical microbiology.
[11] B. Wong,et al. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. , 1985, Reviews of infectious diseases.
[12] W. Merz. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance , 1984, Journal of clinical microbiology.
[13] F. Witebsky,et al. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. , 1982, The American journal of medicine.
[14] J. Wingard,et al. The value of fungal surveillance cultures as predictors of systemic fungal infections. , 1980, The Journal of infectious diseases.
[15] W. Merz,et al. Incidence of polyene-resistant yeasts recovered from clinical specimens , 1980, Antimicrobial Agents and Chemotherapy.
[16] R. D. King,et al. Adherence of Candida albicans and other Candida species to mucosal epithelial cells , 1980, Infection and immunity.
[17] J. Wingard,et al. Candida tropicalis: a major pathogen in immunocompromised patients. , 1979, Annals of internal medicine.
[18] J. Aisner,et al. Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization. , 1976, The American journal of medicine.